Synthetic Biology

IntegrateRNA Launches Custom Aminoacyl-tRNA Synthesis Service to Advance Protein Engineering Research
IntegrateRNA's new Aminoacyl-tRNA In Vitro Synthesis Service enables researchers to create custom proteins with non-canonical amino acids, potentially accelerating drug discovery and biotechnology development.
August 31, 2025

EnPlusOne Biosciences Aims to Revolutionize RNA Therapeutics with Enzymatic Synthesis
EnPlusOne Biosciences, under the leadership of CEO Clare Murray Ph.D., is pioneering an enzymatic approach to RNA synthesis, addressing the limitations of current methods and paving the way for scalable, pure, and environmentally friendly RNA therapeutics.
August 5, 2025